Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Far be it from me to disagree with a CFA...Fut

I am looking on the top of the first page in the initial report dated 11/27/2006 under "ownership and valuation" there are 369.5 million shares OS (which I believe was basic shares OS) While in today's report "ownership and valuation" shows the diluted shares - 413 million.

 

TIA 

Share
New Message
Please login to post a reply